top of page

Mwandishi

Mhariri:

Imeboreshwa:

< Orodha kuu

ULY CLINIC

ULY CLINIC

Jumanne, 14 Julai 2026, 23:07:34 UTC

Respiratory failure management

Respiratory failure management

Respiratory failure is a clinical condition that occurs when the respiratory system fails to maintain its primary function of gas exchange, resulting in:

  • PaO₂ less than 60 mmHg and/or

  • PaCO₂ greater than 50 mmHg

Respiratory failure is classified according to arterial blood gas abnormalities into Type I (hypoxemic) and Type II (hypercapnic) respiratory failure.


Classification


Type I respiratory failure (hypoxemic respiratory failure)

Type I respiratory failure is characterized by:

  • PaO₂ less than 60 mmHg

  • Normal or reduced PaCO₂

In this type, gas exchange is impaired at the alveolar-capillary membrane.

Examples include:

  • Cardiogenic pulmonary oedema

  • Non-cardiogenic pulmonary oedema

  • Severe pneumonia


Type II respiratory failure (hypercapnic respiratory failure)

Type II respiratory failure is characterized by:

  • PaCO₂ greater than 50 mmHg

Hypoxaemia is common and occurs due to respiratory pump failure.


Investigations


Arterial blood gas analysis

  • Arterial blood gas (ABG)


Haematological investigations

  • Full blood picture (FBP)


Cardiac investigations

  • Electrocardiography (ECG)

  • Echocardiography (ECHO)

  • Troponin-I

  • Creatine kinase


Endocrine investigations

  • Thyroid-stimulating hormone (TSH)


Respiratory investigations

  • Chest X-ray (CXR)

  • Pulmonary function tests (PFTs), if the patient is able to perform them


Biochemical investigations

  • Electrolytes

  • Creatinine

  • Blood urea nitrogen (BUN)

  • AST

  • ALT

  • ALP

  • GGT

  • Albumin

  • Total bilirubin

  • Direct bilirubin


Non-pharmacological treatment


Non-invasive ventilatory support

  • Recommended for patients with mild-to-moderate acute respiratory failure.


Mechanical ventilation

  • Mechanical ventilation may be required in severe respiratory failure.

Note: Refer to the management of cardiogenic pulmonary oedema and acute exacerbations of chronic obstructive pulmonary disease (COPD) for specific ventilatory management strategies in obstructive lung disease.

Imeandikwa:

Jumatatu, 22 Juni 2026, 11:56:24 UTC

References:

bottom of page